Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Magnetic resonance imaging in psoriatic arthritis: a review of the literature. | Available online http content 8 2 207 Review Magnetic resonance imaging in psoriatic arthritis a review of the literature Fiona McQueen1 Marissa Lassere2 and Mikkel Ostergaard3 1 Department of Molecular Medicine and Pathology Faculty of Medicine and Health Sciences University of Auckland Auckland New Zealand 2Department of Rheumatology St George Hospital University of New South Wales New South Wales Australia 3Department of Rheumatology Copenhagen University Hospitals at Hvidovre and Herlev Copenhagen Denmark Corresponding author Fiona McQueen Published 23 March 2006 This article is online at http content 8 2 207 2006 BioMed Central Ltd Arthritis Research Therapy 2006 8 207 doi ar1934 Abstract Psoriatic arthritis is a diverse condition that may be characterized by peripheral inflammatory arthritis axial involvement dactylitis and enthesitis. Magnetic resonance imaging MRI allows visualization of soft tissue articular and entheseal lesions and provides a unique picture of the disease process that cannot be gained using other imaging modalities. This review focuses on the literature on MRI in psoriatic arthritis published from 1996 to July 2005. The MRI features discussed include synovitis tendonitis dactylitis bone oedema bone erosions soft tissue oedema spondylitis sacroiliitis and subclinical arthropathy. Comparisons have been drawn with the more extensive literature describing the MRI features of rheumatoid arthritis and ankylosing spondylitis. Introduction Magnetic resonance imaging MRI has advanced our understanding of many types of arthritis both with respect to inflammatory processes and articular damage. Psoriatic arthritis PsA has received less research scrutiny than rheumatoid arthritis RA in many areas including imaging 1 but this is likely to change because MRI outcome measures are increasingly being used in clinical trials of new therapeutic agents such as biologics 2 . In .
